| 8.485 0.125 (1.5%) | 10-24 14:56 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 10.3 | 1-year : | 12.03 |
| Resists | First : | 8.81 | Second : | 10.3 |
| Pivot price | 8.18  |
|||
| Supports | First : | 8.13 | Second : | 7.71 |
| MAs | MA(5) : | 8.51 |
MA(20) : | 8.15 |
| MA(100) : | 8.07  |
MA(250) : | 8.23 |
|
| MACD | MACD : | 0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 75.6 |
D(3) : | 85.1 |
| RSI | RSI(14): 57.9 |
|||
| 52-week | High : | 10.9 | Low : | 6.46 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ EHAB ] has closed below upper band by 20.0%. Bollinger Bands are 23.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 8.76 - 8.8 | 8.8 - 8.83 |
| Low: | 8.24 - 8.29 | 8.29 - 8.33 |
| Close: | 8.28 - 8.36 | 8.36 - 8.42 |
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company also offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. As of March 31, 2022, it operated in 252 home health agencies and 99 hospice agencies across 34 states. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was incorporated in 2014 and is headquartered in Dallas, Texas. As of July 1, 2022, Enhabit, Inc. operates as a standalone company.
Thu, 16 Oct 2025
Enhabit Home Health & Hospice Announces Date of 2025 Third Quarter Earnings Call - Business Wire
Wed, 15 Oct 2025
EHAB Stock Price and Chart — NYSE:EHAB - TradingView
Mon, 29 Sep 2025
Enhabit Advocates Against Proposed Medicare Cuts - TipRanks
Wed, 13 Aug 2025
Enhabit CEO On Her Exit From The Company Amid ‘Challenging’ Home Health Environment - Home Health Care News
Thu, 07 Aug 2025
Earnings call transcript: Enhabit Inc. Q2 2025 earnings beat boosts stock 15% - Investing.com
Wed, 06 Aug 2025
Enhabit Home Health & Hospice Announces CEO Transition Plan - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 51 (M) |
| Shares Float | 40 (M) |
| Held by Insiders | 3.4 (%) |
| Held by Institutions | 102.9 (%) |
| Shares Short | 1,730 (K) |
| Shares Short P.Month | 1,650 (K) |
| EPS | -2.67 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 10.92 |
| Profit Margin | -12.9 % |
| Operating Margin | 6.2 % |
| Return on Assets (ttm) | 2.5 % |
| Return on Equity (ttm) | -20.4 % |
| Qtrly Rev. Growth | 2 % |
| Gross Profit (p.s.) | 10 |
| Sales Per Share | 20.51 |
| EBITDA (p.s.) | 1.64 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 53 (M) |
| Levered Free Cash Flow | 50 (M) |
| PE Ratio | -3.2 |
| PEG Ratio | 0 |
| Price to Book value | 0.77 |
| Price to Sales | 0.41 |
| Price to Cash Flow | 8.16 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|